Large genome models used to design new viruses - Ars Technica
Viral hallucinations Large genome models used to design new viruses The AI system makes genetically distant versions of a bacteria-killing virus. 53 Credit: THOM LEACH / SCIENCE PHOTO LIBRARY Credit: THOM LEACH / SCIENCE PHOTO LIBRARY Text settings Story text Size Small Standard Large Width * Standard Wide Links Standard Orange * Subscribers only Learn more Minimize to nav A lot of the AI work in biology has been focused on designing proteins.
A 25-year Northwestern study of people over 80 with memory as sharp as adults decades younger found that diet and exercise habits varied widely among them, but strong social connection was the one trait they consistently shared - Silicon Canals
Mind A 25-year Northwestern study of people over 80 with memory as sharp as adults decades younger found that diet and exercise habits varied widely among them, but strong social connection was the one trait they consistently shared What keeps a mind sharp into old age may matter less than who keeps you sharp. Some people in their eighties score on memory tests as well as adults twenty to thirty years younger, a pattern researchers at Northwestern University have spent a quarter of a century trying to understand.
A woman went to "hell and back" before her rare disease diagnosis. Then she saw the same symptoms in her sister. - CBS News
Updated on: August 1, 2026 / 11:27 AM EDT / CBS News Megan Kaverman knew something was wrong with her. At 18, she had started to experience some weight gain and shortness of breath, but her family doctor "never figured out what was going on." Soon, the symptoms became so commonplace that she barely noticed them.
The HIV shot that could change medicine is facing its biggest test: Getting to patients - Business Insider
For the first time in the four-decade fight against HIV, there is a "miracle" drug that can all but eliminate the risk of infection, but in the Latin American countries where it was tested, most people can't afford it. Trials show that lenacapavir, made by Gilead Sciences, is almost 100% effective in preventing HIV infection.